Dr Ahmed received his medical degree and internship training in Khartoum, Sudan before moving to Ireland in 2007.

He completed his basic medical training in St James’s Hospital and Tallaght University Hospital. He completed his Higher Specialist Training in clinical and laboratory haematology in Ireland in 2019.

• MD: Royal College of Surgeons in Ireland (RCSI), CSI “Surface markers in CLL as predictors for time to first treatment and targets to the retinoid acitretin”
• FRCPath: Fellowship of the Royal College of Pathologists, UK
• European Haematology Certificate
• Dip HSM: Diploma in Health Services Management: The Institute of Commercial Management (IMC), Bournemouth, England
• MRCPI: Membership of the Royal College of Physicians Ireland
• MBBS (Hons): Bachelor of Medicine and Bachelor of Surgery Omdurman Islamic University, Khartoum, Sudan

• Thrombosis
• Cancer associated thrombosis
• Bleeding disorders

• International Society on Thrombosis and Haemostasis
• Haematology Association of Ireland
• British Society for Haematology
• American Society of Haematology

Dr Ahmed is the hospital’s lead investigator in a multicentre clinical study (TILLIRI Study), investigating incidence and risk factors for deep vein thrombosis (DVT) in patients who require lower limb immobilisation. He is also a sub-investigator in the first gene therapy trial in haemophilia in Ireland “UniQure study” and in Haven trial (phase III trial of emicizumab prophylaxis in haemophilia A patients).

His research on the mechanisms of the increase in factor IX (FIX) levels in children with haemophilia B Leyden, was published at the British Journal of Haematology and presented at the European Haematology Association Congress.

Dr Ahmed conducted basic laboratory research in chronic lymphocytic leukaemia at the Royal College of Surgeons in Ireland (RCSI), The Laboratory for Molecular Medicine and Beaumont Hospital for two years and presented his research at national and international meetings.